A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

BACKGROUND: In 2001, two hexavalent vaccines were licensed in Italy (Hexavac(®), Infanrix Hexa(®)), and since 2002 were extensively used for primary immunization in the first year of life (at 3, 5, 11/12 months of age). In 2005, the market authorization of Hexavac(® )was precautionary suspended by E...

Descripción completa

Detalles Bibliográficos
Autores principales: Giambi, Cristina, Bella, Antonino, Barale, Antonella, Montù, Domenico, Marchisio, Maria, Oddone, Maurizio, Zito, Salvatore, Rapicetta, Maria, Chionne, Paola, Madonna, Elisabetta, Atti, Marta L Ciofi degli
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527316/
https://www.ncbi.nlm.nih.gov/pubmed/18662386
http://dx.doi.org/10.1186/1471-2334-8-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527316/
https://www.ncbi.nlm.nih.gov/pubmed/18662386
http://dx.doi.org/10.1186/1471-2334-8-100

Ejemplares similares